We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IMC market cap is 17.77M. The company's latest EPS is AUD -0.0305 and P/E is -2.62.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 2.99M | 763k | 1.72M | 4.4M | 8.31M |
| Operating Income | -2.92M | -7.07M | -3.11M | -3.71M | -6.68M |
| Net Income | -2.93M | -8.38M | -2.85M | -3.79M | -6.94M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 6.2M | 27.05M | 24.86M | 21.99M | 15.55M |
| Total Liabilities | 558k | 1.16M | 1.68M | 2.37M | 2.84M |
| Total Equity | 5.64M | 25.9M | 23.18M | 19.62M | 12.71M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -3.15M | -4.08M | -3.15M | -2.6M | -5.88M |
| Investing | -1,000 | 3k | 12k | -2.62M | 327k |
| Financing | 1.16M | 26.48M | -42k | -45k | 1,000 |
| Market Cap | 17.77M |
| Price to Earnings Ratio | -2.62 |
| Price to Sales Ratio | 2.19 |
| Price to Cash Ratio | 1.56 |
| Price to Book Ratio | 1.43 |
| Dividend Yield | - |
| Shares Outstanding | 227.8M |
| Average Volume (1 week) | 49.52k |
| Average Volume (1 Month) | 438.95k |
| 52 Week Change | 6.85% |
| 52 Week High | 0.17 |
| 52 Week Low | 0.065 |
| Spread (Intraday) | 0.01 (8.24%) |
| Company Name | Immuron Limited |
| Address |
unit 10 melbourne, victoria 3130 |
| Website | https://www.immuron.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
